Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Renal Cell × pamiparib × Clear all

Sponsor

Conditions

Glioblastoma 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Solid Tumor 1 Neuroectodermal Tumors 1 Nervous System Diseases 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasms 1 Metastatic Castration-Resistant Prostate Cancer (mCRPC) 1 HER2-negative Breast Cancer 1 Gliosarcoma 1 Central Nervous System Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Sunitinib 56 Nivolumab 37 Everolimus 29 Bevacizumab 29 pembrolizumab 24 Sorafenib 23 pazopanib 22 Axitinib 21 aldesleukin 13 Ipilimumab 13 cabozantinib 12 temsirolimus 11 Interferon alpha-2 10 Cyclophosphamide 10 Interleukin-2 9 Radiosurgery 8 Magnetic Resonance Spectroscopy 8 Gemcitabine 8 Immunoglobulin G 7 Erlotinib Hydrochloride 7 Disulfides 6 lenvatinib 5 fludarabine phosphate 5 avelumab 5 Radiotherapy 5 Fluorodeoxyglucose F18 5 peginterferon alfa-2b 4 atezolizumab 4 Nephrectomy 4 Interferon-alpha 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡